Davidson M B
Am J Med Sci. 1986 Jul;292(1):35-9. doi: 10.1097/00000441-198607000-00007.
The available evidence concerning the pathogenesis of type 2 diabetes mellitus suggests that although insulin antagonism is common to many patient groups (i.e., obese, older), overt NIDDM will only develop in a subset who may have a genetic susceptibility for inadequate beta-cell reserves. Since the role of a receptor defect in causing type 2 diabetes is doubtful, the insulin antagonism in these patients is due to a post-receptor defect.
关于2型糖尿病发病机制的现有证据表明,尽管胰岛素拮抗在许多患者群体(即肥胖者、老年人)中很常见,但显性非胰岛素依赖型糖尿病仅在可能具有β细胞储备不足遗传易感性的亚组中发生。由于受体缺陷在2型糖尿病病因中的作用尚不确定,这些患者的胰岛素拮抗是由受体后缺陷引起的。